Tα1 · Zadaxin (where approved)
Thymosin Alpha-1
Labeled in some countries Immune peptide
What it is
Thymosin alpha-1 is a 28-amino-acid thymic peptide used in some countries as thymalfasin for selected viral and immune indications. Research vials are not that licensed product.
Benefits in plain language
What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.
- Zadaxin / thymalfasin is an approved immune-modulating peptide in some countries.
- Studied to help T-cell signaling — infections, vaccine response, some immune-low states.
- This is immunology, not a pump or a tan.
If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.
Mechanism of action
Described as promoting T-cell maturation and modulating innate/adaptive responses rather than a single-receptor “stimulant.”
Possible side effects / caveats
Injection-site irritation, flu-like symptoms, and the usual product-quality gap for research material. Immune activation is not automatically desirable.
Protocol ranges
| Source tier | Amount | Frequency / duration | Notes |
|---|---|---|---|
| Regional label pattern | 1.6 mg | Twice weekly SC | Zadaxin-style figure; indication-specific |